Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial
Edited by Nirmalya Sen | Monday January 11, 2021The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials
AstraZeneca's Covid-19 Vaccine Set To Become First One Approved In India: Report
Edited by Nirmalya Sen | Friday January 01, 2021Britain and Argentina have already authorised the vaccine for urgent public use
Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients
Edited by Nirmalya Sen | Wednesday December 30, 2020Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity
India Dry Runs Vaccine Delivery Systems Ahead Of Emergency Approval
Edited by Nirmalya Sen | Monday December 28, 2020Covid-19 Vaccine: India aims to deliver 600 million coronavirus shots over the next six to eight months starting in January
Turkey Says China's Sinovac Covid-19 Vaccine, CoronaVac, 91.25% Effective In Late Trials
Edited by Nirmalya Sen | Friday December 25, 2020Sinovac Covid-19 Vaccine: Turkish researchers said no major side-effects were seen during their trial, apart from one person who had an allergic reaction
Pfizer, US Seal 100 Million Covid-19 Vaccine Deal With Additional 70 Million Due By June
Reuters | Thursday December 24, 2020Covid-19 vaccine: Pfizer said last week it could need the US government to help it secure some components needed to make the vaccine
Aurobindo Pharma To Make And Sell COVAXX's Covid-19 Vaccine for India, UNICEF
Reuters | Thursday December 24, 2020Covid-19 vaccine: The Indian drugmaker has non-exclusive rights to sell the shot, which is currently undergoing an early-stage trial, in several emerging markets
Tests Expected To Confirm Existing Vaccines Also Effective Against New Covid-19 Variant
Edited by Nirmalya Sen | Wednesday December 23, 2020In the event that the variant presents vaccine developers with an unexpected challenge, an advantage of mRNA is that scientists can quickly reengineer genetic material in the shot to match that of the mutated protein
Volume Decline Muted Pharmaceutical Market Growth In November
Edited by Nikita Prasad | Tuesday December 22, 2020The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products
Where Does The World's Pharmacy Stand In The Covid-19 Vaccine Hunt?
Edited by Nirmalya Sen | Monday December 21, 2020An effective vaccine for India needs to be an affordable vaccine that can be made in large quantities and delivered easily, ideally in a single dose
Two Doses Of Oxford/AstraZeneca Vaccine Prompts Good Immune Response: Early Data Reveals
Edited by Nirmalya Sen | Friday December 18, 2020Data published earlier from later Phase 3 trials showed efficacy was 62 per cent for trial participants given two full doses
Amazon Eyeing This Potential $100 Million Investment In India: Report
Reuters | Wednesday December 09, 2020, BengaluruGrowth of e-pharmacies has left many traders in the country feeling threatened, who say online drugstores can contribute to medicine sales without proper verification
Pfizer Clarifies Covid-19 Vaccine Storage Concerns for India Market
Edited by Nirmalya Sen | Monday December 07, 2020Coronavirus vaccine update: Pfizer requires a temperature of minus 70 degrees Celsius for storage of its vaccine
UK Bets On Millions Of Pfizer-BioNTech Vaccine Doses This Year: Minister
Edited by Nirmalya Sen | Friday December 04, 2020Britain has used an emergency approval process to jump ahead of the EU and US in rollout plans of the vaccine
Dr. Reddy's And RDIF Commence Clinical Trials For Sputnik V Vaccine In India
Edited by Nirmalya Sen | Tuesday December 01, 2020The clinical trials are being conducted by JSS Medical Research as the clinical research partner
